"欧州がん実践規範"の実施展望:ポーランドからの教訓

Joanna Kufel-Grabowska¹, Jacek Jassem¹

¹Department and Clinic of Oncology and Radiotherapy, Medical University of Gdańsk, Poland.

Health policy (Amsterdam, Netherlands)

|February 18, 2026

まとめ

ポーランドで欧州がん実践規範 (ECCP) の実施は,人材不足や不平等なアクセスなどの障壁に直面しています. これに対処するには,がん治療の公平性を高めるために,労働力,組織,文化的変化が必要です.

科学分野:

腫瘍学腫瘍学
医療サービス研究医療サービス
患者の権利患者の権利

背景:

欧州がん実践規範 (ECCP) は,がん治療の公平性,質,患者中心性を高めるために,10の患者の権利を概説しています.
特に中東ヨーロッパでは,ECCPの国内実施に関するデータはほとんどありません.

研究の目的:

ポーランドにおける欧州がん実践規範 (ECCP) の実施の実現可能性の認識を評価する.
実施の課題と機会を特定するために,ECCPの採用に対する国の準備度を評価する.

主な方法:

ポーランドの腫瘍学専門医と精神腫瘍学者に配布された2024年の横断的なオンライン調査.
各ECCPの権利の実現可能性は,5ポイントのリッカースケールで評価され,フリーテキストコメントのテーマ分析によって補足されました.

主要な成果:

225人の専門家が可行性評価を提供し,345人がコメントを提出した. 最も実現可能な権利として認識された権利には,情報へのアクセス,共同意思決定,優先事項に関する議論が含まれています.
最適なケアへの平等なアクセス,構造化された生存/リハビリテーション計画,そして多学科的なチームケアを実現する上で重要な課題が特定されました.
報告された主な障壁は,人材不足,十分な相談時間,診断/治療へのアクセスにおける格差,および文化的な態度であった.

結論:

ポーランドでECCPを成功裏に実施するには,労働力,組織,文化的障害を克服する必要があります.
改善の優先事項には,国家臨床試験登録制度の設立,多学科ユニットの強化,リハビリテーション,緩和ケア,コミュニケーショントレーニングの強化が含まれます.
提案された行動は実現可能であり,欧州の他の保健医療システムに潜在的に移行可能であるとみなされます.

キーワード:

がん治療の公平性についてがん患者の権利がん患者の権利がん対策政策の実施 "欧州がん治療法典"について医療システムの障壁医療システムの障壁ポーランドポーランドポーランドポーランドがん治療の質について

さらに関連する動画

09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

9.2K

05:18

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

11.8K

関連する概念動画

01:21

Cancer Survival Analysis

788

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

788

02:59

Cancer Prevention

8.2K

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

8.2K

02:56

Treatment Resistant Cancers

3.8K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.8K

02:57

Targeted Cancer Therapies

9.0K

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

9.0K

01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

11.5K

02:50

Combination Therapies and Personalized Medicine

6.2K

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...